Among patients with PsA, MetS is associated with certain degenerative changes in the spine and entheses but not with peripheral or axial radiographic damage.

Over a 10-year period, METS-IR effectively predicted CV events among patients with PsA, with values greater than 2.48 at baseline conferring the greatest risk.

Brands like Tilt Beauty, Seen and Tower 28 are marketing their products with special seals of approval. Here's how they get ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Apremilast treatment in patients with psoriatic arthritis leads to favorable changes in body composition and improves disease ...

Factors associated with multi-b/tsDMARD failure among patients with PsA included female sex, obesity, depression, axial disease, and increased disease activity.

A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity -- two issues that commonly co-occur with ...

Researchers have established that uveitis (a severe inflammatory eye disease) is bidirectionally linked to psoriatic ...

Sandoz's antitrust suit against Amgen, the FDA’s interchangeability designation for Celltrion’s adalimumab biosimilar, and ...

HealthCentral, a leading digital health platform serving patients living with chronic and serious illness, has launched HealthCentral Communities, a first-of-its-kind approach that merges ...

Learn more about whether Alvotech or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Alvotech or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...